Rare Disease Groups Welcome FDA’s Embrace of ‘Real World’ Data in Clinical Trials US Lawmakers Urge Bipartisan Support for Rare Disease Research, Patients’ Needs IONIS-HTTRx Shows Promising Results in Phase 1/2 Clinical Trial HDSA Expands List of Huntington’s Disease Centers of Excellence to 43 for 2018 Huntington Chile
